Literature DB >> 12795577

Which treatment for whom for ADHD? Moderators of treatment response in the MTA.

Elizabeth B Owens1, Stephen P Hinshaw, Helen C Kraemer, L Eugene Arnold, Howard B Abikoff, Dennis P Cantwell, C Keith Conners, Glen Elliott, Laurence L Greenhill, Lily Hechtman, Betsy Hoza, Peter S Jensen, John S March, Jeffrey H Newcorn, William E Pelham, Joanne B Severe, James M Swanson, Benedetto Vitiello, Karen C Wells, Timothy Wigal.   

Abstract

Using receiver operating characteristics, the authors examined outcome predictors (variables associated with outcome regardless of treatment) and moderators (variables identifying subgroups with differential treatment effectiveness) in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (ADHD; MTA). Treatment response was determined using parent- and teacher-reported ADHD and oppositional defiant symptoms, with levels near or within the normal range indicating excellent response. Among 9 baseline child and family characteristics, none predicted but 3 moderated treatment response. In medication management and combined treatments, parental depressive symptoms and severity of child ADHD were associated with decreased rates of excellent response; when these 2 characteristics were present, below-average child IQ was an additional moderator. No predictors or moderators emerged for behavioral and community comparison treatments. The authors discuss conceptual and clinical implications of research on treatment moderators.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795577     DOI: 10.1037/0022-006x.71.3.540

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  88 in total

1.  Screening parents during child evaluations: exploring parent and child psychopathology in the same clinic.

Authors:  Hilary B Vidair; Jazmin A Reyes; Sa Shen; Maria A Parrilla-Escobar; Charlotte M Heleniak; Ilene L Hollin; Scott Woodruff; J Blake Turner; Moira A Rynn
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-04-05       Impact factor: 8.829

2.  Measuring youths' perceptions of counseling impact: description, psychometric evaluation, and longitudinal examination of the Youth Counseling Impact Scale v.2.

Authors:  Marcia A Kearns; M Michele Athay; Manuel Riemer
Journal:  Adm Policy Ment Health       Date:  2012-03

3.  What have we learned about trial design from NIMH-funded pragmatic trials?

Authors:  John March; Helena C Kraemer; Madhukar Trivedi; John Csernansky; John Davis; Terence A Ketter; Ira D Glick
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

4.  Pharmacotherapy for parents with attention-deficit hyperactivity disorder (ADHD): impact on maternal ADHD and parenting.

Authors:  Andrea Chronis-Tuscano; Mark A Stein
Journal:  CNS Drugs       Date:  2012-09-01       Impact factor: 5.749

5.  RDoC and Psychopathology among Youth: Misplaced Assumptions and an Agenda for Future Research.

Authors:  Theodore P Beauchaine; Stephen P Hinshaw
Journal:  J Clin Child Adolesc Psychol       Date:  2020 May-Jun

6.  Maternal depressive symptomatology and parenting behavior: exploration of possible mediators.

Authors:  Alyson C Gerdes; Betsy Hoza; L Eugene Arnold; William E Pelham; James M Swanson; Timothy Wigal; Peter S Jensen
Journal:  J Abnorm Child Psychol       Date:  2007-08-03

7.  The Role of Parental ADHD in Sustaining the Effects of a Family-School Intervention for ADHD.

Authors:  Anne E Dawson; Brian T Wymbs; Stephen A Marshall; Jennifer A Mautone; Thomas J Power
Journal:  J Clin Child Adolesc Psychol       Date:  2014-12-13

8.  Treatment of attention deficit hyperactivity disorder in children. Predictors of treatment outcome.

Authors:  Saskia van der Oord; P J M Prins; J Oosterlaan; P M G Emmelkamp
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

9.  The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.

Authors:  Jeffrey M Lackner; Laurie Keefer; James Jaccard; Rebecca Firth; Darren Brenner; Jason Bratten; Laura J Dunlap; Changxing Ma; Mark Byroads
Journal:  Contemp Clin Trials       Date:  2012-07-28       Impact factor: 2.226

10.  Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.

Authors:  Reut Gruber; Ridha Joober; Natalie Grizenko; Bennett L Leventhal; Edwin H Cook; Mark A Stein
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-06       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.